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Abstract of thesis presented to the Senate of Universiti Putra Malaysia in 
fulfillment of the requirement for the degree of Master of Science 
INHIBITORY ACTIVITIES OF A PROBIOTIC BACTERIUM 
(BIFIDOBACTERIUM PSEUDOCA TANULATUM ) ON A COMMON 
DIARRHEAGENIC PATHOGEN (SALM ONELLA ENTERICA) IN HUMAN 
By 
ANIS SHOBIRIN MEOR HUSSIN 
May 2003 
Chairman: Associate Professor Dr. Mohd Yazid Abdul  Manap 
Faculty: Food Science and Biotechnology 
Sixteen strains of Salmonella were isolated from clinically diagnosed 
diarrhea patients. They were tested against a range of antimicrobial agents, and 
typed by serological test and RAPD fingerprinting. All the strains have the 
similar pattern of antimicrobial susceptibility. The serological test has typed 
them into 3 serovars but the RAPD fingerprinting has classed them into 2 major 
clusters. Three strains of bifidobacteria were analyzed for their survival rate in 
human stomach condition. It showed that the ability of bifidobacteria to survive 
was strains dependant. Bifidobacterium pseudocatanulatum F 1 1 7  and 
Bifidobacterium infantis can survive at pH value of human stomach after 
exposure for 90 minutes but not Bifidobacterium pseudocatanulatum G48. The 
survival of bifidobacteria was higher in the pH after meal compared to the pH 
before meal (fasted state). The dose effect study demonstrated, that the initial 
concentration of bifidobacteria would affect the duration of inhibitory activity 
11l 
against Salmonella. Lower in itial concentration exhibit greater inh ibitory activity. 
The inhibition of Salmonella was due to the production of acetate and lactate by 
bifidobacteria and the effectiveness was higher at low pH.  Acetate and lactate 
production was excessive when the initial concentration of bifidobacteria was 
low due to the high growth rates, metabol ism, and competition of energy 
sources. 
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Enam belas strain Salmonella telah dipencilkan daripada pesakit diarea 
yang telah didiagnosa secara klinikal . Ujian terhadap beberapa agen antibiotik 
telah dilakukan terhadap pencilan tersebut dan ia telah dikelaskan melalui ujian 
serologi dan capjari RAPD. Kesemua strain tersebut mempunyai corak 
ketahanan yang sama terhadap semua antibiotik yang digunakan . Ujian 
serologi telah mengkelaskannya kepada 3 jenis serovar manakala capjari 
RAPD kepada 2 kluster utama. Tiga strain bifidobacteria telah melalui ujian 
keupayaan untuk hidup pada keadaan dalam perut manusia. Ujian tersebut 
menunjukan keupayaan bifidobacteria untuk hidup dalam perut manusia adalah 
bergantung kepada jenis strain .  Bifidobacterium pseudocatanulatum F117 dan 
Bifidobacterium infantis ATCC 27920 masih mampu hidup pada nilai pH dalam 
v 
perut manusia setelah 90 minit d idedahkan pada keadaan tersebut tetapi tidak 
bagi Bifidobacterium pseudocatanula tum G48. Kemampuan untuk hidup 
bifidobacteria adalah lebih tinggi pada pH dalam perut selepas makan 
berbanding sebelum makan.  Kaj ian kesan dos mempamerkan kepekatan 
permulaan bifidobacteria akan memberi kesan kepada jangkamasa aktiviti 
perencatan terhadap Sa lmonella. Kepekatan permulaan yang rendah 
mempamerkan aktiviti perencatan yang lebih cepat. Perencatan Salmonella 
adalah d isebabkan oleh penghasi lan asid asetik dan asid laktik oleh 
bifidobacteria. Dan keberkesanannya adalah lebih baik pada pH rendah. 
Penghasi lan asid asetik dan asid laktik adalah lebih t inggi apabi la kepekatan 
permulaan bifidobacteria adalah rendah . I n i  adalah disebabkan oleh kadar 
pertumbuhan dan metabolisma yang tingg i ,  dan pertandingan untuk sumber 
tenaga. 
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CHAPTER 1 
INTRODUCTION 
Infectious diarrhea is a worldwide publ ic health problem. In many 
developing countries, d iarrheal d iseases remained a leading cause of i l lness 
and death among infants and chi ldren (Snyder and Merson, 1982; Ho et al. , 
1988). I n  more developed nations, nosocomial ly acquired diarrheal d isease can 
significantly lengthened hospital stays and increase both d i rect and indirect 
medical costs (Saavedra, 2000). The most serious aspect of this disease is fluid 
loss with resultant dehydration and electrolyte disturbances. In most cases, 
replacing lost flu id to prevent dehydration is the only treatment necessary. The 
use of oral rehydration solutions (ORS) is the main treatment, but it does not 
shorten the recovery of diarrhea. 
Bacterial pathogens probably cause less than 20 % of cases of acute 
childhood diarrhea (Moffet, 1989). This incidence rises in warm climates, 
particularly where sanitary conditions are poor. Global ly, Salmonella, Shigella 
and Campylobaeter remain major contributors to diarrheal d iseases (Stutman, 
1994; L iesenfeld et al. , 1993). Some strains of Escherichia coli, a normal 
inhabitant of the d istal bowel ,  are pathogenic, causing sporadic cases of acute 
enteritis, epidemic d iarrhea (particularly i n  young infants) and traveler's 
diarrhea. Severe diarrhea i n  children has now been attributed to enteroadherent 
strains of E. coli. I n  Malaysia, investigation for common d iarrheal bacteria has 
not much been documented .  
Numerous pro biotic agents have been studied i n  the management 
of infectious d iarrheal diseases (Saveedra et al. , 1 994; H i lton et aI., 1 996; 
Shornikova et aI., 1 997). Prel iminary experimental and cl inical findings show 
that probiotics are emerging as an important, new therapy for preventing and 
treating infectious d iarrhea (Saavedra, 2000). I ngestion of probiotics can exert a 
positive i nfluence on the health or physiology of the host. It was bel ieved that it 
could infl uence intestinal physiology either directly or indirectly through 
modulation of the endogenous ecosystem or immune system. 
Bifidobacteria ,  a pro biotic, comprised a major group i n  the human and 
animal i ntestinal flora along with bacteroides and eubacteria. They are thought 
to exert some of the protective effect against acute diarrhea diseases. 
B ifidobacteria are Gram positive, non-acid fast, non-spore forming and non­
moti le organism. These organisms have been isolated from the faeces of 
breast-fed infant, adu lt human intestine, vagina and mouth as wel l  as in the 
al imentary tract of various kinds of animal (Rasic and Kurman , 1 983; Yazid et 
al., 1 999). In the large i ntestine, bifidobacteria produce acetic and lactic acids 
and is thought to inh ibit the proliferation of putrefactive bacteria such as 
escherichiae, clostrid ia and eubacteria .  
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In order to use bifidobacteria as an alternative to manage acute 
d iarrhea, it is necessary to establish the strain that can survive in the acidic 
conditions of the stomach . And also, the dose of the bifidobacteria that is able 
to reduce the growth of the causative microorganism should a lso be 
established . Consideri ng these reasons, the objectives of the present study are: 
a) To isolate and characterize the major d iarrheagenic pathogens from 
stool of acute diarrhea patients below 3 years of age 
b) To study the dose-effect of Bifidobacterium spp. against the 
Salmonella spp. in s imulated human colon environment 
3 
CHAPTER 2 
LITERATURE REVIEW 
2.1  Etiology of Bifidobacteria spp. 
Bifidobacteria were first isolated from the faeces of breast-fed infants by 
Tissier ( 1 990), who used the name Bacillus bitidus communis. Today, this 
genus, which belongs to the Actinomycetaceae group, i ncludes 30 species 
including nine species found in human (Ishibashi et al., 1 997) . Bitidobacterium 
are general ly characterized as Gram-positive, non-sporeforming rods with 
bifurcating pleomorphic cel lu lar morphology, non-moti le and catalase negative 
(Rasic and Kurman, 1 983). Bifidobacteria are anaerobic microorganisms but 
some species can tolerate oxygen only in the presence of carbon d ioxide 
(Scardovi ,  1 986). The colonies may be smooth , convex to pulvinate , entire 
edges, cream to wh ite, gl istening and soft consistency depending on nutritional 
condition and strain characteristics. Most human strains of bifidobacteria grow 
at an optimum temperature of 37-38 °C (Rasic, 1 983). 
2.2 Inhibitory Activity of Bifidobacteria 
Bifidobacteria are known as probiotic organ isms because of the potentia l 
beneficial roles of bifidobacteria i n  the i ntestinal  tract of humans (Hughes and 
4 
Hoover, 1991). These bacteria were shown to play a slgnlTlcant rOle In 
controlling the acidity of the large intestinal tract and capable of hydrolyzing 
indigestible complex carbohydrate such as lactulose, into acetic and lactic 
acids. These acids are responsible for maintaining the intestinal microbial 
balance by inhibiting the growth of potential pathogens (Rasic,1983). 
In vitro study by Araya-Kojima et al. (1995) shows that the inhibitory 
effects of bifidobacteria were due to the decreased of pH resulting from the 
synthesis of lactic and acetic acids. It may also compete with a pathogen for 
luminal nutrients that are rates limiting substrates or occupy adhesion receptors 
and inhibit attachment to the mucosa (Bernet et a/., 1994). There may be 
indirect effects that result from enhancement of host responses such as 
activation of microphages or stimulation of secretary antibody (Kaila et al., 
1992). These possible mechanisms would be dependent on the ability of the 
probiotic to survive and colonize the gut. 
2.3 Probiotics and Acute Diarrhea 
Probiotic, have iong been suggested to have a role in the management 
of diarrheal diseases. The best-established benefit of using probiotic agents has 
been in the management of acute pediatric diarrheal disease. Several large and 
well-controlled studies showed a significant decrease in the duration of diarrhea 
in children who received Lactobacillus GG, either as a supplement or in 
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